Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Structure Therapeutics Inc. | 51,804 | reported | 23 Jun 2025 | tx 7+623,812−534,508 |
| PROTHENA CORP PUBLIC LTD CO | 27,000 | reported | 15 May 2026 | tx 4+194,183 |
| Nuvation Bio Inc. | 19,547 | reported | 24 May 2024 | tx 10+1,730,351−659,947 |
| Ultragenyx Pharmaceutical Inc. | 14,058 | reported | 14 May 2026 | tx 24+139,416 |
| INTERCEPT PHARMACEUTICALS INC | 2,966 | reported | 28 May 2020 | tx 14+23,901−819 |
| AveXis, Inc. | 0 | reported | 15 May 2018 | tx 9+43,123−40,911 |
| SEATTLE GENETICS INC /WA | 0 | reported | 14 Dec 2023 | tx 145+403,606−417,081 |
| HYPERION THERAPEUTICS INC | 0 | reported | 07 May 2015 | tx 8+37,286−37,286 |
| INTERMUNE INC | 0 | reported | 29 Sept 2014 | tx 133+3,301,314−2,998,344 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 May 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 7,751 | 0.00 USD | |
| 14 May 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 14,058 | 0.00 USD | deriv |
| 15 May 2026 | GRANT_AWARD | PROTHENA CORP PUBLIC LTD CO | 27,000 | 0.00 USD | deriv |
| 23 Jun 2025 | GRANT_AWARD | Structure Therapeutics Inc. | 51,804 | 0.00 USD | deriv |
| 15 May 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 5,740 | 0.00 USD | |
| 15 May 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 10,787 | 0.00 USD | deriv |
| 14 May 2025 | GRANT_AWARD | PROTHENA CORP PUBLIC LTD CO | 20,183 | 0.00 USD | deriv |
| 25 Jun 2024 | GRANT_AWARD | Structure Therapeutics Inc. | 37,500 | 0.00 USD | deriv |
| 18 Jun 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 5,345 | 0.00 USD | |
| 18 Jun 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 9,900 | 0.00 USD | deriv |
| 24 May 2024 | EXERCISE | Nuvation Bio Inc. | 293,203 | 1.74 USD | |
| 24 May 2024 | EXERCISE | Nuvation Bio Inc. | 366,744 | 1.64 USD | |
| 24 May 2024 | EXERCISE | Nuvation Bio Inc. | 366,744 | 0.00 USD | deriv |
| 24 May 2024 | EXERCISE | Nuvation Bio Inc. | 293,203 | 0.00 USD | deriv |
| 15 May 2024 | GRANT_AWARD | PROTHENA CORP PUBLIC LTD CO | 15,000 | 0.00 USD | deriv |
| 21 Feb 2024 | GRANT_AWARD | PROTHENA CORP PUBLIC LTD CO | 132,000 | 0.00 USD | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 4,750 | 229.00 USD | |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 10,725 | 229.00 USD | |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 2,044 | — | deriv |
| 28 Aug 2023 | EXERCISE | SEATTLE GENETICS INC /WA | 1,812 | 135.63 USD | |
| 28 Aug 2023 | SALE | SEATTLE GENETICS INC /WA | 1,610 | 209.08 USD | |
| 28 Aug 2023 | SALE | SEATTLE GENETICS INC /WA | 1,812 | 209.01 USD | |
| 28 Aug 2023 | SALE | SEATTLE GENETICS INC /WA | 1,503 | 209.16 USD | |
| 28 Aug 2023 | EXERCISE | SEATTLE GENETICS INC /WA | 1,812 | 0.00 USD | deriv |
| 03 Aug 2023 | OTHER | Structure Therapeutics Inc. | 411,000 | 7.97 USD | deriv |